Volt are delighted to attend The Financial Times US Pharma & Biotech Summit 5-6th May 2021. Volt's Jonathan Richards, Managing Consultant, Life Sciences - Medical Affairs & Clinical Development Recruitment will be attending.
​Volt were proud sponsors in the FT US Pharma and Biotech Summit 2020 and look forward to attending again this year alongside Fortune 100 organizations.

Event bio: The FT US Pharma and Biotech Summit is the essential annual event for professionals interested in the latest developments in drug discovery, clinical trials, market access, manufacturing and supply chains. CEOs, thought leaders and policymakers will discuss how the pharma industry is adapting to meet a new set of challenges and opportunities for the post-pandemic era.

Speaker list & Agenda:

• Mike McDermott (President, Pfizer Global Supply)
• Robert Bradway (Chairman and CEO, Amgen)
• Kabir Nath (President and CEO, Otsuka North America)
• Alisha Alaimo (President, Biogen U.S. Organization)
• All speakers here

Some of the topics covered this year:

• Pharma's big moment: Collaborating in a crisis
• New Dawn: Sustaining renewed public trust in the pharma industry
• Navigating the pharma investment landscape
• Politics and pricing: How will pending US healthcare reform affect pharma?
• Analysis: The Us biosimilars market
• Pharmaceutical portfolio management strategy
• Adapting pharma company culture to the rise of AI
• Driving the digital transformation of pharma R&D
• Unlock the full potential of RNA therapeutics
• CAR-T and beyond: Forging the future of cell and gene therapies
• Futurizing pharma workforces
• Reshaping pharma supply chains